Poging GOUD - Vrij

On a wing and a prayer

Business Standard

|

October 28, 2024

The Jharkhand Assembly elections will see electors cast their vote on November 13 and 20. SHIKHA CHATURVEDI analyses how food inflation, poverty, and promises are playing out in the fiscally-strained state

- SHIKHA CHATURVEDI

On a wing and a prayer

The electoral battle in Jharkhand is intensifying as alliances evolve ahead of the Assembly elections. Currently, the coalition of Jharkhand Mukti Morcha (JMM) and Congress governs the state, with Hemant Soren back in the chief minister's seat. The Bharatiya Janata Party (BJP), the principal opposition in the state, aims to improve its performance after losing to the JMM-Congress combine in 2019, following a five-year rule from 2014 to 2019. This year, the BJP has allied with the All Jharkhand Students Union (AJSU).

To attract voters, purse strings are being loosened. The JMM-led government has launched the Mukhyamantri Maiya Samman Yojana (MMSY), providing ₹1,000 per month to eligible women aged 21 to 50. Last month, the state Cabinet lowered the minimum age limit to 18. Currently, 4,815,048 women are registered, with 4,536,597 receiving benefits.

The government plans to increase payouts to ₹2,500 per month in December to further enhance this initiative. This increase, aimed at countering the BJP's proposed 'Gogo Didi Yojana' which promises ₹2,100 per month to women, is expected to hit the state exchequer by ₹9,000 crore a year.

However, financing these initiatives poses challenges, as Jharkhand generates only about 30.8 per cent of its revenue receipts from its own tax collections. Additionally, the state's finances are strained by a comprehensive pension scheme that provides universal coverage, lowering the qualifying age for old-age pensions from 60 to 50 years for marginalized groups, including Dalits, Adivasis, and women. The state government supplements central pension amounts, contributing an additional ₹240.4 crore to ensure all eligible individuals receive ₹1,000 a month.

MEER VERHALEN VAN Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size